Purchases and Sales Made in Q4 2024 in Alx Oncology Holdings Inc (ALXO)
This table provides information about the institutional ownership of Alx Oncology Holdings Inc (ALXO) during Q4 2024. The information is specifically focused on institutions that hold shares of ALX ONCOLOGY HOLDINGS INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2025
Q4 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 14, 2025
Q4 2024
|
Group One Trading, L.P.
Chicago, IL |
SELL
|
- |
-203- 1.33% |
$246 - $380
|
15.1K
$24.8K
|
|
|
Feb 05, 2025
Q4 2024
|
Hc Advisors, LLC
|
SELL
|
- |
-300- 1.9% |
$363 - $561
|
15.5K
$25.4K
|
|
|
Jul 02, 2025
Q4 2024
|
Bank Of Nova Scotia
|
SELL
|
- |
-552- 0.52% |
$668 - $1.03K
|
105K
$173K
|
|
|
Feb 07, 2025
Q4 2024
|
Zurcher Kantonalbank (Zurich Cantonalbank)
Zurich, V8 |
SELL
|
- |
-1.01K- 80.95% |
$1.22K - $1.88K
|
237
$389
|
|
|
Feb 13, 2025
Q4 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-2.35K- 31.93% |
$2.84K - $4.39K
|
5K
$8.2K
|
|
|
Feb 11, 2025
Q4 2024
|
Simplex Trading, LLC
|
SELL
|
- |
-2.58K- 15.04% |
$3.12K - $4.82K
|
14.6K
$23.9K
|
|
|
Jan 17, 2025
Q4 2024
|
Sg Americas Securities, LLC
|
SELL
|
- |
-3.14K- 11.46% |
$3.8K - $5.87K
|
24.3K
$39.8K
|
|
|
May 29, 2025
Q4 2024
|
Rhumbline Advisers
Boston, MA |
SELL
|
- |
-3.79K- 8.18% |
$4.58K - $7.08K
|
42.5K
$69.7K
|
|
|
Feb 14, 2025
Q4 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-6.96K- 83.2% |
$8.43K - $13K
|
1.41K
$2.31K
|
|
|
Feb 14, 2025
Q4 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-7.46K- 26.74% |
$9.03K - $14K
|
20.5K
$33.5K
|
|
|
Feb 06, 2025
Q4 2024
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-8.6K- 3.81% |
$10.4K - $16.1K
|
217K
$355K
|
|
|
Feb 13, 2025
Q4 2024
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-11.4K- 30.32% |
$13.8K - $21.3K
|
26.2K
$43K
|
|
|
Feb 14, 2025
Q4 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-34.5K- 11.89% |
$41.8K - $64.5K
|
256K
$420K
|
|
|
Feb 13, 2025
Q4 2024
|
Xtx Topco LTD
London, X0 |
SELL
|
- |
-53.5K- 16.85% |
$64.7K - $100K
|
264K
$433K
|
|
|
Feb 14, 2025
Q4 2024
|
Redmile Group, LLC
San Francisco, CA |
SELL
|
- |
-147K- 3.83% |
$178K - $275K
|
3.69M
$6.05M
|
|
|
Feb 14, 2025
Q4 2024
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-319K- 69.75% |
$386K - $597K
|
138K
$227K
|
|
|
Feb 14, 2025
Q4 2024
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
- |
-351K- 91.65% |
$425K - $657K
|
32K
$52.5K
|
|
|
Feb 14, 2025
Q4 2024
|
Tang Capital Management LLC
San Diego, CA |
SELL
|
- |
-908K- 21.59% |
$1.1M - $1.7M
|
3.3M
$5.41M
|
|
|
Feb 14, 2025
Q4 2024
|
Bio Impact Capital LLC
Cambridge, MA |
SELL
|
- |
-1.02M- 42.26% |
$1.23M - $1.9M
|
1.39M
$2.28M
|